Search research articles
Contact Us
Filters
Showing results (51-60 of 72) with videos related to
Page
of 8
Sort By:
BMC Cancer
|
April 1, 2014
A phase II study of cisplatin with intravenous and oral vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy with oral vinorelbine and cisplatin for locally advanced non-small cell lung cancer
Delphine Lerouge, Alain Rivière, Eric Dansin, et al.
Journal of the American College of Cardiology
|
January 13, 2018
Selective EGF-Receptor Inhibition in CD4<sup>+</sup> T Cells Induces Anergy and Limits Atherosclerosis
Lynda Zeboudj, Mikael Maître, Lea Guyonnet, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 3, 2015
The Tumor Antigen Cyclin B1 Hosts Multiple CD4 T Cell Epitopes Differently Recognized by Pre-Existing Naive and Memory Cells in Both Healthy and Cancer Donors
Claire Chevaleyre, Nadine Benhamouda, Emmanuel Favry, et al.
Clinical Nutrition (Edinburgh, Scotland)
|
April 4, 2026
Resting energy expenditure as a predictor of immune checkpoint inhibitors response in older patients with non-small cell metastatic lung cancer: A pooled analysis of two prospective cohort studies
Marie Pautas, Pascaline Boudou-Rouquette, Anne Jouinot, et al.
Pharmaceutics
|
September 23, 2022
Exposure-Response Analysis of Osimertinib in Patients with Advanced Non-Small-Cell Lung Cancer
Thomas Rodier, Alicja Puszkiel, Evelina Cardoso, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 13, 2012
Analysis of spontaneous tumor-specific CD4 T-cell immunity in lung cancer using promiscuous HLA-DR telomerase-derived epitopes: potential synergistic effect with chemotherapy response
Yann Godet, Elizabeth Fabre, Magalie Dosset, et al.
British Journal of Cancer
|
July 31, 2019
Distinct prognostic value of circulating anti-telomerase CD4<sup>+</sup> Th1 immunity and exhausted PD-1<sup>+</sup>/TIM-3<sup>+</sup> T cells in lung cancer
Caroline Laheurte, Magalie Dosset, Dewi Vernerey, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
May 28, 2024
Adverse myocardial and vascular side effects of immune checkpoint inhibitors: a prospective multimodal cardiovascular assessment
Mariana Mirabel, Assié Eslami, Constance Thibault, et al.
Pathology
|
June 4, 2024
Successive next-generation sequencing strategy for optimal fusion gene detection in non-small-cell lung cancer in clinical practice
Simon Garinet, Audrey Lupo, Thomas Denize, et al.
Cancers
|
February 23, 2020
Predictive Value of Soluble PD-1, PD-L1, VEGFA, CD40 Ligand and CD44 for Nivolumab Therapy in Advanced Non-Small Cell Lung Cancer: A Case-Control Study
Manuela Tiako Meyo, Anne Jouinot, Etienne Giroux-Leprieur, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 72) with videos related to
Sort By:
Page
of 8
BMC Cancer
|
April 1, 2014
A phase II study of cisplatin with intravenous and oral vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy with oral vinorelbine and cisplatin for locally advanced non-small cell lung cancer
Delphine Lerouge, Alain Rivière, Eric Dansin, et al.
Journal of the American College of Cardiology
|
January 13, 2018
Selective EGF-Receptor Inhibition in CD4<sup>+</sup> T Cells Induces Anergy and Limits Atherosclerosis
Lynda Zeboudj, Mikael Maître, Lea Guyonnet, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 3, 2015
The Tumor Antigen Cyclin B1 Hosts Multiple CD4 T Cell Epitopes Differently Recognized by Pre-Existing Naive and Memory Cells in Both Healthy and Cancer Donors
Claire Chevaleyre, Nadine Benhamouda, Emmanuel Favry, et al.
Clinical Nutrition (Edinburgh, Scotland)
|
April 4, 2026
Resting energy expenditure as a predictor of immune checkpoint inhibitors response in older patients with non-small cell metastatic lung cancer: A pooled analysis of two prospective cohort studies
Marie Pautas, Pascaline Boudou-Rouquette, Anne Jouinot, et al.
Pharmaceutics
|
September 23, 2022
Exposure-Response Analysis of Osimertinib in Patients with Advanced Non-Small-Cell Lung Cancer
Thomas Rodier, Alicja Puszkiel, Evelina Cardoso, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 13, 2012
Analysis of spontaneous tumor-specific CD4 T-cell immunity in lung cancer using promiscuous HLA-DR telomerase-derived epitopes: potential synergistic effect with chemotherapy response
Yann Godet, Elizabeth Fabre, Magalie Dosset, et al.
British Journal of Cancer
|
July 31, 2019
Distinct prognostic value of circulating anti-telomerase CD4<sup>+</sup> Th1 immunity and exhausted PD-1<sup>+</sup>/TIM-3<sup>+</sup> T cells in lung cancer
Caroline Laheurte, Magalie Dosset, Dewi Vernerey, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
May 28, 2024
Adverse myocardial and vascular side effects of immune checkpoint inhibitors: a prospective multimodal cardiovascular assessment
Mariana Mirabel, Assié Eslami, Constance Thibault, et al.
Pathology
|
June 4, 2024
Successive next-generation sequencing strategy for optimal fusion gene detection in non-small-cell lung cancer in clinical practice
Simon Garinet, Audrey Lupo, Thomas Denize, et al.
Cancers
|
February 23, 2020
Predictive Value of Soluble PD-1, PD-L1, VEGFA, CD40 Ligand and CD44 for Nivolumab Therapy in Advanced Non-Small Cell Lung Cancer: A Case-Control Study
Manuela Tiako Meyo, Anne Jouinot, Etienne Giroux-Leprieur, et al.
Page
of 8